Novartis Neoral Patient Assistance Proposal Violates Kickback Laws, IG Says
Novartis will have to work through a third party if it wants to proceed with a program to help low-income Medicare patients afford their portion of costs for the cyclosporine products Neoral and Sandimmune
You may also be interested in...
The Pharmaceutical Research & Manufacturers of America is launching an online verification system for its member companies' patient assistance programs
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011